Live Breaking News & Updates on Fosun Kite Biotechnology Co Ltd|Page 2

Stay updated with breaking news from Fosun kite biotechnology co ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NDA for New Second-Line Indication of CAR T-Cell Therapy Product YIKAIDA (Axicabtagene Ciloleucel Injection) Approved for CDE Review

Fosun Kite to Participate in the Fifth CIIE to Showcase New Options in Cell Therapy SHANGHAI, Oct. 27, 2022 /PRNewswire/ October 24 brought go. ....

Huang Hai , Monica Li , Kite Pharma Inc , National Medical Products Administration , Fosun Kite Biotechnology Co Ltd , Axicabtagene Ciloleucel Cell Therapy Center , Fosun Kite , Showcase New Options , Cell Therapy , Drug Evaluation , Kite Pharma ,

NDA for New Second-Line Indication of CAR T-Cell Therapy Product YIKAIDA (Axicabtagene Ciloleucel Injection) Approved for CDE Review

/PRNewswire/ October 24 brought good news from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) that the NDA for. ....

Huang Hai , Monica Li , Kite Pharma Inc , National Medical Products Administration , Fosun Kite Biotechnology Co Ltd , Axicabtagene Ciloleucel Cell Therapy Center , Fosun Kite , Showcase New Options , Cell Therapy , Drug Evaluation , Kite Pharma ,

Neukio Biotherapeutics completes financing round for cell therapy products

Neukio Biotherapeutics, a Chinese company committed to developing novel cell therapy products, has closed $50M in a series A-1 funding round. ....

Yescarca Axicabtagene Ciloleucel , Richard Liqun Wang , Neukio Biotherapeutics , Fosun Kite Biotechnology Co Ltd , Alwin Capital , Surplus Capital , Lilly Asia Ventures , Sherpa Healthcare Partners , Simbay Park , Shanghai Pilot Free Trade Zone , Liqun Wang , Axicabtagene Ciloleucel ,

Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products

/PRNewswire/ Neukio Biotherapeutics, a company committed to developing novel cell therapy products, announces it has closed $50 million in a Series A-1. ....

Hong Kong , Yescarca Axicabtagene Ciloleucel , Prnewswire Neukio Biotherapeutics , Richard Liqun Wang , Neukio Biotherapeutics , Silkroad Law Firm , Fosun Kite Biotechnology Co Ltd , Alwin Capital , Surplus Capital , Lilly Asia Ventures , Sherpa Healthcare Partners , Simbay Park , Shanghai Pilot Free Trade Zone , Axicabtagene Ciloleucel , Alwin Capita , Healthcare Partners , Neukio Therapeutics , Health Care Amp Hospitals , Medical Pharmaceuticals , Venture Capital ,

Cancer treatment by Fosun reaches new user milestone

More than 200 adult cancer patients in China have been treated with the CAR-T cell therapy by Shanghai-based Fosun Kite Biotechnology Co Ltd following its market approval in the country in June last year, the company said on Thursday. ....

Wang Li , Huang Hai , Gilead Company , Shanghai Fosun Pharmaceutical Group , Fosun Kite Biotechnology Co Ltd , Shanghai Based Fosun Kite Biotechnology Co Ltd , Shanghai Ruijin Hospital , Fosun Kite , Car T ,